Analysis of three different equations for predicting quadriceps femoris muscle strength in patients with COPD;Análise de três diferentes fórmulas de predição de força muscular do quadríceps femoral em pacientes com DPOC

Jornal Brasileiro de Pneumologia

Volumn 41, Issue 4, 2015, Pages 305-312

  Nellessen, Aline Gonçalves ^a   Donária, Leila ^a   Hernandes, Nidia Aparecida ^a   Pitta, Fabio ^a  

^a STATE UNIVERSITY OF LONDRINA   (Brazil)

Author keywords

Chronic obstructive; Muscle strength; Pulmonary disease; Quadriceps muscle; Reference values

Indexed keywords

AGE; AGED; ALGORITHM; BODY HEIGHT; BODY MASS; BODY WEIGHT; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; DYNAMOMETER; FEMALE; HEALTH SERVICE; HUMAN; KNEE; LUNG FUNCTION TEST; MALE; MIDDLE AGED; MUSCLE ISOMETRIC CONTRACTION; MUSCLE STRENGTH; MUSCLE WEAKNESS; OBESITY; PATHOPHYSIOLOGY; PHYSIOLOGY; PREDICTIVE VALUE; QUADRICEPS FEMORIS MUSCLE; SEX DIFFERENCE; TRENDS;

ADIPOSITY; AGE FACTORS; AGED; ALGORITHMS; BODY HEIGHT; BODY MASS INDEX; BODY WEIGHT; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH SERVICES NEEDS AND DEMAND; HUMANS; ISOMETRIC CONTRACTION; KNEE; MALE; MIDDLE AGED; MUSCLE STRENGTH; MUSCLE STRENGTH DYNAMOMETER; MUSCLE WEAKNESS; PREDICTIVE VALUE OF TESTS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUADRICEPS MUSCLE; RESPIRATORY FUNCTION TESTS; SEX FACTORS;

EID: 84941920048     PISSN: 18063713     EISSN: 18063756     Source Type: Journal    
DOI: 10.1590/S1806-37132015000004515     Document Type: Article

References (33)

1. Global Strategy for Chronic Obstructive Lung Disease [homepage on the Internet]. Bethesda: Global Initiative for Chronic Obstructive Lung Disease. [cited 2014 Sep 15]. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease; 2014 Available from: http://www.goldcopd.org/Guidelines/guidelines-resources.html
2. Agustí AG, Noguera A, Sauleda J, Sala E, Pons J, Busquets X. Systemic effects of chronic obstructive pulmonary disease. Eur Respir J. 2003;21(2):347-360. http://dx.doi. org/10.1183/09031936.03.00405703
3. Miranda EF, Malaguti C, Corso SD. Peripheral muscle dysfunction in COPD: lower limbs versus upper limbs. J Bras Pneumol. 2011;37(3):380-388. http://dx.doi.org/10.1590/S1806-37132011000300016
4. Dourado VZ, Tanni SE, Vale SA, Faganello MM, Sanchez FF, Godoy I. Systemic manifestations in chronic obstructive pulmonary disease. J Bras Pneumol. 2006;32(2):161-171.
5. Gea J, Agustí A, Roca J. Pathophysiology of muscle dysfunction in COPD. J Appl Physiol (1985). 2013;114(9):1222-1234. http://dx.doi.org/10.1152/japplphysiol.00981.2012
6. Gea J, Orozco-Levi M, Barreiro E, Ferrer A, Broquetas J. Structural and functional changes in the skeletal muscles of COPD patients: the “compartments” theory. Monaldi Arch Chest Dis. 2001;56(3):214-224.
7. Hopkinson NS, Tennant RC, Dayer MJ, Swallow EB, Hansel TT, Moxham J, et al. A prospective study of decline in fat free mass and skeletal muscle strength in chronic obstructive pulmonary disease. Respir Res. 2007;8:25. http://dx.doi.org/10.1186/1465-9921-8-25
8. Seymour JM, Spruit MA, Hopkinson NS, Natanek SA, Man WD, Jackson A, et al. The prevalence of quadriceps weakness in COPD and the relationship with disease severity. Eur Respir J. 2010;36(1):81-8. http://dx.doi. org/10.1183/09031936.00104909
9. Maltais F, Decramer M, Casaburi R, Barreiro E, Burelle Y, Debigaré R, et al. An official American Thoracic Society/European Respiratory Society statement: update on limb muscle dysfunction in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2014;189(9):e15-e62. http://dx.doi.org/10.1164/rccm.201402-0373ST
10. Gosselink R, Troosters T, Decramer M. Peripheral muscle weakness contributes to exercise limitation in COPD. Am J Respir Crit Care Med. 1996;153(3):976-980. http://dx.doi.org/10.1164/ajrccm.153.3.8630582
11. Mostert R, Goris A, Weling-Scheepers C, Wouters EF, Schols AM. Tissue depletion and health related quality of life in patients with chronic obstructive pulmonary disease. Respir Med. 2000;94(9):859-867. http://dx.doi. org/10.1053/rmed.2000.0829
12. Decramer M, Gosselink R, Troosters T, Verschueren M, Evers G. Muscle weakness is related to utilization of health care resources in COPD patients. Eur Respir J. 1997;10(2):417-423. http://dx.doi.org/10.1183/09031936.97.10020417
13. Swallow EB, Reyes D, Hopkinson NS, Man WD, Porcher R, Cetti EJ, et al. Quadriceps strength predicts mortality in patients with moderate to severe chronic obstructive pulmonary disease. Thorax. 2007;62(2):115-120. http://dx.doi.org/10.1136/thx.2006.062026
14. Robles PG, Mathur S, Janaudis-Fereira T, Dolmage TE, Goldstein RS, Brooks D. Measurement of peripheral muscle strength in individuals with chronic obstructive pulmonary disease: a systematic review. J Cardiopulm Rehabil Prev. 2011;31(1):11-24. http://dx.doi.org/10.1097/HCR.0b013e3181ebf302
15. Gosselink R, Troosters T, Decramer M. Distribution of muscle weakness in patients with stable chronic obstructive pulmonary disease. J Cardiopulm Rehabil. 2000;20(6):353-360. http://dx.doi.org/10.1097/00008483-200011000-00004
16. Neder JA, Nery LE, Shinzato GT, Andrade MS, Peres C, Silva AC. Reference values for concentric knee isokinetic strength and power in nonathletic men and women from 20 to 80 years old. J Orthop Sports Phys Ther. 1999;29(2):116-126. http://dx.doi.org/10.2519/jospt.1999.29.2.116
17. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al. Standardisation of spirometry. Eur Respir J. 2005;26(2):319-338. http://dx.doi.org/10.1183/09031936.05.00034805
18. Pereira CA, Sato T, Rodrigues SC. New reference values for forced spirometry in white adults in Brazil. J Bras Pneumol. 2007;33(4):397-406. http://dx.doi.org/10.1590/S1806-37132007000400008
19. Lukaski HC, Bolonchuk WW, Hall CB, Siders WA. Validation of tetrapolar bioelectrical impedance method to assess human body composition. J Appl Physiol (1985). 1986;60(4):1327-1332.
20. Kyle UG, Pichard C, Rochat T, Slosman DO, Fitting JW, Thiebaud D. New bioelectrical impedance formula for patients with respiratory insufficiency: comparison to dual-energy X-ray absorptiometry. Eur Respir J. 1998;12(4):960-6. http://dx.doi.org/10.1183/09031936.98.12040960
21. O’Shea SD, Taylor NF, Paratz JD. Measuring muscle strength for people with chronic obstructive pulmonary disease: retest reliability of hand-held dynamometry. Arch Phys Med Rehabil. 2007;88(1):32-36. http://dx.doi. org/10.1016/j.apmr.2006.10.002
22. Lienhard K, Lauermann SP, Schneider D, Item-Glatthorn JF, Casartelli NC, Maffiuletti NA. Validity and reliability of isometric, isokinetic and isoinertial modalities for the assessment of quadriceps muscle strength in patients with total knee arthroplasty. J Electromyogr Kinesiol. 2013;23(6):1283-8. http://dx.doi.org/10.1016/j.jelekin.2013.09.004
23. Thorstensson A, Grimby G, Karlsson J. Force-velocity relations and fiber composition in human knee extensor muscles. J Appl Physiol. 1976;40(1):12-6.
24. Sillen MJ, Franssen FM, Delbressine JM, Vaes AW, Wouters EF, Spruit MA. Efficacy of lower-limb muscle training modalities in severely dyspnoeic individuals with COPD and quadriceps muscle weakness: results from the DICES trial. Thorax. 2014;69(6):525-531. http://dx.doi. org/10.1136/thoraxjnl-2013-204388
25. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33(1):159-74. http://dx.doi.org/10.2307/2529310
26. Menezes AM, Jardim JR, Pérez-Padilla R, Camelier A, Rosa F, Nascimento O, et al. Prevalence of chronic obstructive pulmonary disease and associated factors: the PLATINO Study in São Paulo, Brazil. Cad Saude Publica. 2005;21(5):1565-73. http://dx.doi.org/10.1590/S0102-311X2005000500030
27. Pitta F, Breyer MK, Hernandes NA, Teixeira D, Sant’Anna TJ, Fontana AD, et al. Comparison of daily physical activity between COPD patients from Central Europe and South America. Respir Med. 2009;103(3):421-6. http://dx.doi.org/10.1016/j.rmed.2008.09.019
28. Hernandes NA, Teixeira Dde C, Probst VS, Brunetto AF, Ramos EM, Pitta F. Profile of the level of physical activity in the daily lives of patients with COPD in Brazil. J Bras Pneumol. 2009;35(10):949-56.
29. Casanova C, Celli BR, Barria P, Casas A, Cote C, de Torres JP, et al. The 6-min walk distance in healthy subjects: reference standards from seven countries. Eur Respir J. 2011;37(1):150-156. http://dx.doi. org/10.1183/09031936.00194909
30. Holland AE, Spruit MA, Troosters T, Puhan MA, Pepin V, Saey D, et al. An official European Respiratory Society/American Thoracic Society technical standard: field walking tests in chronic respiratory disease. Eur Respir J. 2014;44(6):1428-1446. http://dx.doi. org/10.1183/09031936.00150314
31. Allaire J, Maltais F, Doyon JF, Noël M, LeBlanc P, Carrier G, et al. Peripheral muscle endurance and the oxidative profile of the quadriceps in patients with COPD. Thorax. 2004;59(8):673-8. http://dx.doi.org/10.1136/thx.2003.020636
32. Probst VS, Troosters T, Heuzel K, Van Bael J, Decramer M, Gosselink R. Comparison of 2 devices for measuring quadriceps force in COPD patients [abstract]. Eur Respir J. 2004;24(Suppl 48):666s.
33. Stark T, Walker B, Phillips JK, Fejer R, Beck R. Hand-held dynamometry correlation with the gold standard isokinetic dynamometry: a systematic review. PM R. 2011;3(5):472-9. http://dx.doi.org/10.1016/j.pmrj.2010.10.025